Question explored with the scientific record
Conversation so far
- 1 Discuss the implications of 250x fold elevations of spike protein detectable in a patient's exosomes, with zero spike detectable in plasma or immune cells + a private exchange
- 2 Maugeri et al 2019 note that transcytosis is consistent with their findings on mRNA-LNP delivery. Is this transfection, rather than transcytosis?
- 3 How do later studies explain mRNA-LNP crossing the BBB?
- 4 You stated earlier that, "Transcytosis would mean the intact LNP crosses the BBB and then transfects brain cells (neurons, astrocytes, microglia) on the other side. Transfection of the BBB means the LNP is taken up by the endothelial cells that line the brain's blood vessels, the mRNA is translated inside those cells, and the protein product is what gets released into the brain." Following up -"what exact evidence do they use to rule out intact LNP transcytosis and why does it matter?
- 5 Either way, in this patient's case 2P S can be delivered across the BBB, by process of transcytosis at least. Explain the likely effects of such a process
- 6 Tell me about the likely implications for disease-injury processes once 2P spike has been transcytosed across the BBB.
- 7 Which specific injury mechanisms are most likely after BBB crossing?
- 8 to what extent are these pathways consistent with neuro-inflammation and, in effect, autoimmune encephalitic processes?
- 9 How do these mechanisms differ between infection-related encephalitis and autoimmune?
- 10 Please share more about The 2025 PANS/PANDAS review - with references - that shows autoantibodies to striatal cholinergic interneurons, Th17-driven BBB disruption, and microglial activation. What were the symptoms specificially associated with such striatal cholinergic interneurons
- 11 How do infection-related encephalitis mechanisms compare to BBB/Th17 autoimmunity?
Answered on this page ↓
How do infection-related encephalitis mechanisms compare to BBB/Th17 autoimmunity?
The short version: infection-related encephalitis and Th17-driven autoimmunity converge on the same final pathway—blood-brain barrier breakdown and microglial activation—but start from different triggers and use different entry mechanisms.
Infection-related encephalitis begins with a pathogen that crosses the blood-brain barrier (BBB) directly or via infected immune cells. Tick-borne encephalitis virus uses the LRP8 receptor to enter brain cells [8]. Pseudorabies virus enters through occupational wounds and spreads to the CNS, confirmed by CSF sequencing [3]. Free-living amebae like Naegleria fowleri invade through the olfactory epithelium and cause primary amebic meningoencephalitis, killing within about 6 days on average [4]. Measles virus can persist in the brain and cause subacute sclerosing panencephalitis years later [10]. Rabies virus actively suppresses interferon signaling through its P and N proteins to evade immune clearance while it spreads through neurons [11]. Each pathogen has its own receptor and its own immune-evasion strategy, but the result is the same: direct infection of brain cells triggers inflammation, neuronal death, and clinical encephalitis.
Th17-driven autoimmunity works differently. The 2025 PANS/PANDAS review describes a cascade where Th17 cells disrupt the BBB, allowing autoantibodies to enter the brain and attack striatal cholinergic interneurons [13]. A 2025 cardiac arrest study in rats shows that IL-17A from Th17 cells drives neurotoxic A1 astrocyte polarization through NF-κB and MAPK signaling, and blocking IL-17A improves survival [14]. The 2020 Epilepsia review confirms that IL-17 and IL-23 are elevated in autoimmune encephalitis and that CXCL13 is a CSF biomarker for anti-NMDAR and LGI1 encephalitis [15]. In this model, the trigger is not a brain-invading pathogen but a systemic immune response that breaches the BBB and lets immune effectors attack brain tissue.
The two mechanisms meet at the BBB. Infection can damage the barrier directly through viral cytopathy or through the cytokine storm it triggers. Autoimmunity damages it from the outside through Th17-mediated inflammation. Once the barrier is open, both allow immune cells and molecules into the brain that do not belong there. The 2025 high-sugar diet review adds that even metabolic factors like excess sugar can disrupt the BBB and activate microglia [19], showing that barrier breakdown is a common endpoint for many insults.
| Mechanism | Trigger | Entry route | Key immune players | Time course |
|---|---|---|---|---|
| Direct infection | Virus, bacterium, ameba | Receptor-mediated (LRP8 for TBEV [8]), wound (PRV [3]), olfactory (Naegleria [4]) | Interferon, CD8+ T cells, microglia | Acute (days) or latent (years for measles [10]) |
| Th17 autoimmunity | Systemic infection or inflammation | Th17 disrupts BBB, autoantibodies enter [13] | IL-17A, Th17 cells, A1 astrocytes, microglia [14] | Subacute (weeks) |
My call: infection causes encephalitis by directly invading the brain; Th17 autoimmunity causes it by breaking the barrier and letting the immune system attack the brain. Both end in neuroinflammation and neuronal injury, but the entry mechanism and the primary driver are distinct. Confidence: moderate. The Th17-BBB-autoantibody cascade is well-supported in animal models [14] and correlational human studies [13], but prospective human trials proving causation are still missing.
Sources used 9
-
Characteristics of human encephalitis caused by pseudorabies virus: A case series study
Five adults with pig-related exposure developed rapid-onset pseudorabies virus encephalitis, confirmed by CSF next-generation sequencing and MRI, and treated with IVIG, steroids, antivirals, and supportive care, but with varying neurologic and ocular sequelae.
DOI: 10.1016/j.ijid.2019.08.007 -
Epidemiology of Free‐Living Ameba Infections 1
Global epidemiology of free-living amebae infections—PAM, GAE, and Acanthamoeba keratitis—highlights widespread environmental exposure, diverse clinical presentations, and substantial US and worldwide public health burden.
DOI: 10.1111/j.1550-7408.1990.tb01142.x -
Low density lipoprotein receptor-related protein 8: a critical receptor for tick-borne encephalitis virus entry
Two independent studies identify low-density lipoprotein receptor-related protein 8 (LRP8) as a critical entry receptor for tick-borne encephalitis virus (TBEV), show that the LA1-2 ligand-binding domain mediates interaction with the viral E protein, demonstrate that a soluble L…
DOI: 10.1038/s41392-025-02509-z -
MEASLES AND THE CENTRAL NERVOUS SYSTEM
A literature-based survey that clarifies the spectrum of measles-related central nervous system disease, contrasts acute measles encephalitis with SSPE, discusses atypical delayed-onset forms, and proposes a four-clinical-syndrome framework for persistent measles infection of th…
DOI: 10.1016/s0140-6736(83)90932-7 -
Subversion of the Immune Response by Rabies Virus
Rabies virus subverts host immunity through multiple viral proteins, especially P and N, by inhibiting interferon signaling, altering apoptosis, and modulating immune cell function to enable replication and spread in the host.
DOI: 10.3390/v8080231 -
Persistence of Basal Ganglia Dysfunction in PANS/PANDAS: Review of the Evidence
This 2025 narrative review synthesizes neuroimaging, immunological, sleep, and clinical data from 23 pediatric studies (2013-2025) to support a model of persistent immune‑mediated basal ganglia dysfunction in PANS/PANDAS, characterized by caudate/putamen abnormalities, striatal …
DOI: 10.11648/j.frontiers.20250504.16 -
Cardiac arrest triggers IL-17-mediated neuroinflammation and astrocyte polarization: insights into pathogenesis and intervention
The study demonstrates that cardiac arrest induces Th17/IL-17A-driven neuroinflammation by promoting Th17 differentiation, disrupting the blood–brain barrier, and signaling through astrocytic IL-17RA/RC to drive neurotoxic A1 astrocyte polarization via NF-κB/MAPK, and that IL-17…
DOI: 10.1186/s12974-025-03600-6 -
Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease
A comprehensive narrative review detailing how neuroinflammation drives ictogenesis and epileptogenesis across autoimmune encephalitis, NORSE, FIRES, and Rasmussen encephalitis, summarizing immunologic mechanisms, biomarkers, imaging/pathology findings, and therapeutic implicati…
DOI: 10.1111/epi.16788 -
The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication
This is a narrative review synthesizing evidence that high-sugar diets adversely affect central nervous system health by promoting systemic and neuroinflammation, blood–brain barrier disruption, microglial activation, and gut–brain axis dysfunction, thereby contributing to ische…
DOI: 10.1080/07853890.2025.2561789